Lightwave Logic (LWLG) 10-K 18 Mar 19 2018 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2018	Mar. 18, 2019	Jun. 30, 2018
Document and Entity Information [Abstract]
Entity Registrant Name	Lightwave Logic, Inc.
Entity Central Index Key	0001325964
Document Type	10-K
Document Period End Date	Dec. 31, 2018
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 84,578,680
Entity Common Stock, Shares Outstanding		80,759,209
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2018

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Dec. 31, 2018	Dec. 31, 2017
CURRENT ASSETS
Cash and cash equivalents	$ 2,174,625	$ 3,482,327
Prepaid expenses and other current assets	337,631	584,919
Total Current Assets	2,512,256	4,067,246
PROPERTY AND EQUIPMENT - NET	1,800,769	1,176,749
OTHER ASSETS
Intangible assets - net	938,239	605,775
TOTAL ASSETS	5,251,264	5,849,770
CURRENT LIABILITIES
Accounts payable	150,741	54,208
Current portion of equipment purchase	178,482	493,597
Accounts payable and accrued expenses - related parties	13,824	8,770
Accrued expenses	1,155	92,186
TOTAL CURRENT LIABILITIES	344,202	648,761
LONG TERM EQUIPMENT PURCHASE - NET OF CURRENT PORTION		184,294
TOTAL LIABILITIES	344,202	833,055
STOCKHOLDERS' EQUITY
Preferred stock, $0.001 par value, 1,000,000 authorized, no shares issued or outstanding
Common stock $0.001 par value, 250,000,000 authorized, 79,176,330 and 74,068,259 issued and outstanding at December 31, 2018 and December 31, 2017	79,177	74,068
Additional paid-in-capital	62,356,854	56,698,658
Accumulated deficit	(57,528,969)	(51,756,011)
TOTAL STOCKHOLDERS' EQUITY	4,907,062	5,016,715
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 5,251,264	$ 5,849,770

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2018	Dec. 31, 2017
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	79,176,330	74,068,259
Common stock, shares outstanding	79,176,330	74,068,259

STATEMENTS OF OPERATIONS

STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Statement [Abstract]
NET SALES
COST AND EXPENSE
Research and development	3,794,565	3,519,129
General and administrative	1,806,451	2,004,409
TOTAL COST AND EXPENSE	5,601,016	5,523,538
LOSS FROM OPERATIONS	(5,601,016)	(5,523,538)
OTHER INCOME (EXPENSE)
Interest income	250	250
Commitment fee	(172,192)	(226,094)
NET LOSS	$ (5,772,958)	$ (5,749,382)
Basic and Diluted Loss per Share	$ (0.08)	$ (0.08)
Basic and Diluted Weighted Average Number of Shares	76,395,750	70,876,576

STATEMENT OF STOCKHOLDERS' EQUI

STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2016	$ 68,078	$ 48,998,073	$ (46,006,629)	$ 3,059,522
Balance, shares at Dec. 31, 2016	68,077,288
Common stock issued to institutional investor	$ 5,300	5,716,760		5,722,060
Common stock issued to institutional investor, shares	5,300,000
Common stock issued for additional commitment shares	$ 186	225,907		226,093
Common stock issued for additional commitment shares, shares	185,974
Exercise of warrants	$ 469	502,031		502,500
Exercise of warrants, shares	469,000
Common stock issued for services	$ 35	44,215		44,250
Common stock issued for services, shares	35,997
Options issued for services		794,738		794,738
Warrants issued for services		416,934		416,934
Net loss			(5,749,382)	(5,749,382)
Balance at Dec. 31, 2017	$ 74,068	56,698,658	(51,756,011)	$ 5,016,715
Balance, shares at Dec. 31, 2017	74,068,259			74,068,259
Common stock issued to institutional investor	$ 4,750	4,858,785		$ 4,863,535
Common stock issued to institutional investor, shares	4,750,000
Common stock issued for additional commitment shares	$ 159	172,033		172,192
Common stock issued for additional commitment shares, shares	158,071
Exercise of options	$ 100	99,900		100,000
Exercise of options, shares	100,000
Exercise of warrants	$ 100	61,400		61,500
Exercise of warrants, shares	100,000
Options issued for services		387,688		387,688
Warrants issued for services		78,390		78,390
Net loss			(5,772,958)	(5,772,958)
Balance at Dec. 31, 2018	$ 79,177	$ 62,356,854	$ (57,528,969)	$ 4,907,062
Balance, shares at Dec. 31, 2018	79,176,330			79,176,330

STATEMENTS OF CASH FLOWS

STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (5,772,958)	$ (5,749,382)
Adjustments to reconcile net loss to net cash used in operating activities
Warrants issued for services	78,390	416,934
Stock options issued for services	387,688	794,738
Common stock issued for services and fees	172,192	270,343
Depreciation and amortization and noncash patent expenses	465,795	325,946
Loss on disposal of property and equipment	10,084
(Increase) decrease in assets
Prepaid expenses and other current assets	247,288	(447,977)
(Decrease) increase in liabilities
Accounts payable	96,533	(10,819)
Accounts payable and accrued expenses-related parties	5,054	3,211
Accrued expenses	(91,031)	34,886
Net cash used in operating activities	(4,400,965)	(4,362,120)
CASH FLOWS FROM INVESTING ACTIVITIES
Cost of intangibles	(397,479)	(81,743)
Purchase of property and equipment	(1,037,384)	(183,789)
Sale of property and equipment	2,500
Net cash used in investing activities	(1,432,363)	(265,532)
CASH FLOWS FROM FINANCING ACTIVITIES
Exercise of options and warrants	161,500	502,500
Issuance of common stock, institutional investor	4,863,535	5,722,060
Repayment of equipment purchase payable	(499,409)	(71,425)
Net cash provided by financing activities	4,525,626	6,153,135
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(1,307,702)	1,525,483
CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR	3,482,327	1,956,844
CASH AND CASH EQUIVALENTS - END OF YEAR	2,174,625	3,482,327
Supplemental Disclosure of Non-cash investing and financing activities:
Equipment acquisition funded by liability		749,316
Common stock for service, paid in advance		$ 36,250

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES History and Nature of Business Lightwave Logic, Inc. is a technology Company focused on the development of next generation photonic devices and non-linear optical polymer materials systems for applications in high speed fiber-optic data communications and optical computing markets. Currently the Company is in various stages of photonic device and materials development and evaluation with potential customers and strategic partners. The Company expects to obtain a revenue stream from datacom and telecom devices, sales of non-linear optical polymers, and product development agreements prior to moving into full-scale production. The Company’s current development activities are subject to significant risks and uncertainties, including failing to secure additional funding to operationalize the Company’s technology now under development. Lightwave Logic, Inc., (the “Company”) was organized under the laws of the State of Nevada in 1997 as Eastern Idaho Internet Service, Inc. The Company was engaged in an unrelated business until June 30, 1998, at which time the principal assets of that business were sold and operations were discontinued. The Company was inactive until the acquisition of PSI-TEC Corporation (“PSI-TEC”) on July 14, 2004, which is when the Company commenced with its current business and changed its name to PSI-TEC Holdings, Inc. Merger On July 14, 2004, the Company acquired PSI-TEC in a share exchange, which was considered to be a capital transaction in substance rather than a business combination, and was accounted for as a change of capital structure under accounting principles generally accepted in the United States. On October 20, 2006, the Company and PSI-TEC merged and the Company changed its name to Third-Order Nanotechnologies, Inc. On March 10, 2008, the Company changed its name to Lightwave Logic, Inc. Basis of Presentation The accompanying financial statements are presented in accordance with accounting principles generally accepted in the United States of America. Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results could differ from the estimates. Cash Equivalents For the purposes of the statement of cash flows, the Company considers all highly liquid instruments with maturities of three months or less at the time of purchase to be cash equivalents. Concentration of Credit Risk Certain financial instruments potentially subject the Company to concentrations of credit risk. These financial instruments consist primarily of cash. At December 31, 2018, the Company did have deposits with a financial institution that exceed the Federal Depository Insurance coverage. Property and Equipment Equipment is stated at cost. Depreciation is principally provided by use of straight-line methods for financial and tax reporting purposes over the estimated useful lives of the assets, generally 5 years. When property is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in operations. Intangible Assets Definite-lived intangible assets are stated at cost. Patents are amortized over their estimated useful lives, commencing from the date of grant for the remaining legal lives of the patents. The patents generally have a term of up to 20 years from the date of filing of the earliest related patent application. When certain patent applications are abandoned by the Company for claims that are covered by patents already granted to the Company, the cost of patent applications are removed from the accounts and the resulting expense is reflected in the statement of operations. Fair Value of Financial Instruments The Company’s financial instruments consist of cash, accounts payable and accrued expenses. The carrying values of cash, accounts payable and accrued expenses approximate fair value because of their short maturities. Income Taxes The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statement and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. Stock-based Payments The Company accounts for stock-based compensation under the provisions of Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 718, "Compensation - Stock Compensation", which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the shorter of the vesting period or the requisite service periods using the straight-line method. The Company accounts for stock-based compensation awards to nonemployees in accordance with FASB ASC 505-50, "Equity- Based Payments to Non-Employees (“ASC 505-50”). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded as an expense and additional paid in capital in stockholders’ equity over the applicable service periods. Non-employee equity based payments are recorded as an expense over the service period, as if the Company had paid cash for the services. At the end of each financial reporting period, prior to vesting or prior to the completion of the services, the fair value of the equity based payments will be re-measured and the non-cash expense recognized during the period will be adjusted accordingly. Since the fair value of equity based payments granted to non-employees is subject to change in the future, the amount of the future expense will include fair value re-measurements until the equity based payments are fully vested or the service completed. As of June 30, 2018 the Company changed its accounting policy for non-employee equity based payments by adopting FASB ASU 2018-07, which expands Topic 718 to include transactions for acquiring goods and services, from nonemployees. Loss Per Share The Company follows FASB ASC 260, “Earnings per Share”, resulting in the presentation of basic and diluted earnings per share. Because the Company reported a net loss in 2018 and 2017, common stock equivalents, including stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and dilutive loss per share were the same. Recoverability of Long-Lived Assets The Company follows FASB ASC 360, “Property, Plant, and Equipment”. Long-lived assets to be held and used are reviewed for impairment whenever events or changes in circumstances indicate that the related carrying amount may not be recoverable. When required, impairment losses on assets to be held and used are recognized based on the excess of the asset’s carrying amount. Comprehensive Income The Company follows FASB ASC 220.10, “Reporting Comprehensive Income.” Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income. Since the Company has no items of other comprehensive income, comprehensive loss is equal to net loss. Recently Adopted Accounting Pronouncements In June 2018, the FASB issued ASU No. 2018-07, Compensation – Stock Compensation (Topic 718), Improvements to Nonemployee Share-Based Payment Accounting. The amendments in this Update expand the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. Prior to this Update, Topic 718 applied only to share-based transactions to employees. Consistent with the accounting requirement for employee share-based payment awards, nonemployee share-based payment awards within the scope of Topic 718 are measured at grant-date fair value of the equity instruments that an entity is obligated to issue when the good has been delivered or the service has been rendered and any other conditions necessary to earn the right to benefit from the instruments have been satisfied. The amendments in this Update are effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. Early adoption is permitted, but no earlier than an entity’s adoption date of Topic 606. The adoption of this pronouncement on June 30, 2018 had no material impact on the Company’s financial statements. Recently Issued Accounting Pronouncements Not Yet Adopted In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) In July 2018, the FASB issued ASU No. 2018-11, Leases (Topic 842), Targeted Improvements Leases The Company is in the process of evaluating the above ASUs and estimating lease liabilities and corresponding right-of-use assets as of January 1, 2019. Reclassifications Certain reclassifications have been made to the 2017 financial statement in order to conform to the 2018 financial statement presentation.

MANAGEMENT'S PLANS

MANAGEMENT'S PLANS	12 Months Ended
	Dec. 31, 2018
MANAGEMENT'S PLANS [Abstract]
MANAGEMENT'S PLANS	NOTE 2 – MANAGEMENT’S PLANS As a technology company focusing on the development of the next generation photonic devices and non-linear optical polymer materials systems, substantial net losses have been incurred since inception. The Company has satisfied capital requirements since inception primarily through the issuance and sale of its common stock. As of March 18, 2019, the Company has a cash position of approximately $2,200,000. Based upon the current cash position and expenditures of approximately $585,000 per month and no debt service, management believes the Company has sufficient funds to finance its operations through June 2019. In January 2016, the Company signed a purchase agreement (“Purchase Agreement”) with an institutional investor to sell up to $20,000,000 of common stock. Under the Purchase Agreement and at Company's sole discretion, the institutional investor has committed to invest up to $20,000,000 in common stock over a 36-month period with the remaining available amount of $7,861,215 as of December 31, 2018. Since December 31, 2018, the Company has raised an additional $1,011,585. In January 2019, the Company signed a Purchase Agreement with the institutional investor to sell up to $25,000,000 of common stock. The Company registered 9,500,000 shares pursuant to a registration statement filed on January 30, 2019 which became effective February 13, 2019.

PREPAID EXPENSES AND OTHER CURR

PREPAID EXPENSES AND OTHER CURRENT ASSETS	12 Months Ended
	Dec. 31, 2018
Prepaid Expense, Current [Abstract]
PREPAID EXPENSES AND OTHER CURRENT ASSETS	NOTE 3 – PREPAID EXPENSES AND OTHER CURRENT ASSETS Prepaid expenses and other current assets consist of the following: December 31, 2018 December 31, 2017 Insurance $ 226,363 $ 79,403 Prepaid material 46,120 — Rent 21,896 254,978 Other 37,210 20,992 Stock award 6,042 30,208 Deposits — 199,338 $ 337,631 $ 584,919

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	12 Months Ended
	Dec. 31, 2018
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	NOTE 4 – PROPERTY AND EQUIPMENT Property and equipment consists of the following: December 31, 2018 December 31, 2017 Office equipment $ 79,886 $ 82,453 Lab equipment 2,513,459 1,695,604 Furniture 33,128 32,693 Leasehold improvements 220,389 231,859 2,846,862 2,042,609 Less: Accumulated depreciation 1,046,093 865,860 $ 1,800,769 $ 1,176,749 Depreciation expense for the years ending December 31, 2018 and 2017 was $400,780 and 182,006. During the year ending December 31, 2018, the Company sold equipment for proceeds of $2,500 and a gain of $2,500. During the year ending December 31, 2018, the Company retired property and equipment and recorded a loss on the retirement of $12,584. During the year ended December 31, 2017, the Company did not sell or retire property and equipment.

INTANGIBLE ASSETS

INTANGIBLE ASSETS	12 Months Ended
	Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS	NOTE 5 – INTANGIBLE ASSETS This represents legal fees and patent fees associated with the prosecution of patent applications. The Company has recorded amortization expense on patents granted, which are amortized over the remaining legal life. Maintenance patent fees are paid to a government patent authority to maintain a granted patent in force. Some countries require the payment of maintenance fees for pending patent applications. Maintenance fees paid after a patent is granted are expensed, as these are considered ongoing costs to “maintain a patent”. Maintenance fees paid prior to a patent grant date are capitalized to patent costs, as these are considered “patent application costs”. No amortization expense has been recorded on the remaining patent applications since patents have yet to be granted. On June 11, 2018, the Company purchased patents for $315,000. Intangible assets consist of the following: December 31, 2018 December 31, 2017 Patents $ 1,184,882 $ 787,403 Less: Accumulated amortization 246,643 181,628 $ 938,239 $ 605,775 Amortization expense for the years ending December 31, 2018 and 2017 was $65,015 and $95,341. There were no patent costs written off for the years ended December 31, 2018. Patent costs in the amount of $48,599 previously capitalized for possible filing of two provisional patents were written off to research and development expenses during the year ended December 31, 2017. After review by the Company, it was decided to keep secret some aspects of its chromophore development and protect them as Trade Secrets and Know-How.

LONG TERM EQUIPMENT PURCHASE PA

LONG TERM EQUIPMENT PURCHASE PAYABLE	12 Months Ended
	Dec. 31, 2018
Payables and Accruals [Abstract]
LONG TERM EQUIPMENT PURCHASE PAYABLE	NOTE 6 – LONG TERM EQUIPMENT PURCHASE PAYABLE Outstanding long term equipment purchase payable is comprised of the following: Final Year Interest December 31, December 31, of Maturity Classification Rate 2018 2017 Current 0.00 % $ 178,482 $ 493,597 2019 Long term 0.00 % — 184,294 $ 178,482 $ 677,891

COMMITMENTS

COMMITMENTS	12 Months Ended
	Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS	NOTE 7 – COMMITMENTS On October 30, 2017, the Company entered into a new lease to lease approximately 13,420 square feet of office, laboratory and research and development space located in Colorado for the Company’s new principal executive offices and research and development facility. The term of the lease is sixty- one (61) months, beginning on November 1, 2017 and ending on November 30, 2022. The term shall be extended for an additional twenty-four (24) months, subject to certain conditions, waivable solely by Landlord in its sole and absolute discretion. Base rent for the first year of the lease term is approximately $168,824, with an increase in annual base rent of approximately 3% in each subsequent year of the lease term. As specified in the lease, the Company paid the landlord (i) all base rent for the period November 1, 2017 and ending on October 31, 2019, in the sum of $347,045; and (ii) the estimated amount of tenant’s proportionate share of operating expenses for the same period in the sum of $186,293. Commencing on November 1, 2019, monthly installments of base rent and one-twelfth of landlord’s estimate of tenant’s proportionate share of annual operating expenses shall be due on the first day of each calendar month. The lease also provides that (i) on November 1, 2019 landlord shall pay the Company for the cost of the cosmetic improvements in the amount of $3.00 per rentable square foot of the premises, and (ii) on or prior to November 1, 2019, the Company shall deposit with Landlord the sum of $36,524 as a security deposit which shall be held by landlord to secure the Company’s obligations under the lease. On October 30, 2017, the Company entered into an agreement with the tenant leasing the premise from the landlord (“Original Lessee”) whereby the Original Lessee agreed to pay the Company the sum of $260,000 in consideration of the Company entering into the lease and landlord agreeing to the early termination of the Original Lessee’s lease agreement with landlord. The consideration of $260,000 was received on November 1, 2017. The Company is obligated under an operating lease for office and laboratory space. The aggregate minimum future lease payments under the operating leases are as follows: YEARS ENDING DECEMBER 31, AMOUNT 2019 $ 32,432 2020 195,574 2021 201,501 2022 189,837 TOTAL $ 619,344 In June 2018, the lease for the facility located in Longmont Colorado was terminated. Rent expense amounting to $149,131 and $51,791 is included in research and development and general and administrative expenses for the year ended December 31, 2018. Rent expense approximating $121,228 and $25,348 is included in research and development and general and administrative expenses for the year ended December 31, 2017.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 8 – INCOME TAXES As discussed in Note 1, the Company utilizes the asset and liability method of accounting for income taxes in accordance with FASB ASC 740. The income tax (benefit) provision consists of the following: 2018 2017 Current $ — $ — Deferred (1,503,000 ) 5,063,000 Change in valuation allowance 1,503,000 (5,063,000 ) $ — $ — The reconciliation of the statutory federal rate to the Company’s effective income tax rate is as follows: 2018 2017 Amount % Amount % Income tax benefit at U.S. federal income tax rate $ (1,213,000 ) (21 ) $ (1,955,000 ) (34 ) State tax benefit, net of federal tax effect (346,000 ) (6 ) (345,000 ) (6 ) Non-deductible share-based compensation 56,000 1 250,000 4 Tax rate change — — 7,113,000 124 Change in valuation allowance 1,503,000 26 (5,063,000 ) (88 ) $ — — $ — — The components of deferred tax assets as of December 31, 2018 and 2017 are as follows: 2018 2017 Deferred tax asset for NOL carryforwards $ 11,892,000 $ 10,440,000 Share-based compensation 1,873,000 1,822,000 Valuation allowance (13,765,000 ) (12,262,000 ) $ — $ — In December 2017, the Tax Cuts and Jobs Act was enacted, which reduces the U.S. statutory corporate tax rate from 34% to 21% for tax years beginning in 2018 which resulted in the re-measurement of the federal portion of the Company’s deferred tax assets and valuation allowance as of December 31, 2017 from 34% to the new 21% tax rate. The valuation allowance for deferred tax assets as of December 31, 2018 and 2017 was $13,765,000 and $12,262,000, respectively. The change in the total valuation for the year ended December 31, 2018 was an increase of $1,503,000 and for the year ended December 31, 2017 was a decrease of $5,063,000. In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which the net operating losses and temporary differences become deductible. Management considered projected future taxable income and tax planning strategies in making this assessment. The value of the deferred tax assets was offset by a valuation allowance, due to the current uncertainty of the future realization of the deferred tax assets. As of December 31, 2018, the Company had net operating loss carry forwards of approximately $44,044,000, expiring through the year ending December 31, 2038. This amount can be used to offset future taxable income of the Company. The timing and manner in which the Company can utilize operating loss carryforwards in any year may be limited by provisions of the Internal Revenue Code regarding changes in ownership of corporations. Such limitation may have an impact on the ultimate realization of its carryforwards and future tax deductions. The Company follows FASB ASC 740.10, which provides guidance for the recognition and measurement of certain tax positions in an enterprise’s financial statements. Recognition involves a determination of whether it is more likely than not that a tax position will be sustained upon examination with the presumption that the tax position will be examined by the appropriate taxing authority having full knowledge of all relevant information. The adoption of FASB ASC 740.10 did not require an adjustment to the Company’s financial statements. The Company’s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the statement of operations. As of January 1, 2018, the Company had no unrecognized tax benefits and no charge during 2018, and accordingly, the Company did not recognize any interest or penalties during 2018 related to unrecognized tax benefits. There is no accrual for uncertain tax positions as of December 31, 2018. The Company files U.S. income tax returns and a state income tax return. With few exceptions, the U.S. and state income tax returns filed for the tax years ending on December 31, 2015 and thereafter are subject to examination by the relevant taxing authorities.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	12 Months Ended
	Dec. 31, 2018
Equity [Abstract]
STOCKHOLDERS' EQUITY	NOTE 9 – STOCKHOLDERS’ EQUITY Preferred Stock Pursuant to the Company’s Articles of Incorporation, the Company’s board of directors is empowered, without stockholder approval, to issue series of preferred stock with any designations, rights and preferences as they may from time to time determine. The rights and preferences of this preferred stock may be superior to the rights and preferences of the Company’s common stock; consequently, preferred stock, if issued could have dividend, liquidation, conversion, voting or other rights that could adversely affect the voting power or other rights of the common stock. Additionally, preferred stock, if issued could be utilized, under special circumstances, as a method of discouraging, delaying or preventing a change in control of the Company’s business or a takeover from a third party. Common Stock Options and Warrants In January 2016, the Company signed a Purchase Agreement with an institutional investor to sell up to $20,000,000 of common stock. The Company also entered into a registration rights agreement with the institutional investor whereby the Company agreed to file a registration statement related to the transaction with the U.S. Securities and Exchange Commission registering 5,000,000 shares of the Company’s common stock. The registration statement was filed on March 25, 2016. The registration statement became effective April 7, 2016. The Company registered an additional 5,000,000 shares pursuant to a registration statement filed on April 19, 2017 which became effective June 15, 2017. The Company registered an additional 5,000,000 shares pursuant to a registration statement filed on May 2, 2018 which became effective May 11, 2018. Under the Purchase Agreement and at Company's sole discretion, the institutional investor has committed to invest up to $20,000,000 in common stock over a 36-month period. The Company issued 350,000 shares of restricted common stock to the institutional investor as an initial commitment fee valued at $237,965, fair value, and 650,000 shares of common stock are reserved for additional commitment fees to the institutional investor in accordance with the terms of the Purchase Agreement. During the period August 2016 through December 31, 2018, the institutional investor purchased 12,450,000 shares of common stock for proceeds of $12,138,785 and the Company issued 394,526 shares of common stock as additional commitment fee, valued at $432,205, fair value, leaving 255,474 in reserve for additional commitment fees. During the year ending December 31, 2018, the institutional investor purchased 4,750,000 shares of common stock for proceeds of $4,863,535 and the Company issued 158,071 shares of common stock as additional commitment fee, valued at $172,192, fair value. During January, through March 2019, the institutional investor purchased 1,550,000 shares of common stock for proceeds of $1,011,585 and the Company issued 32,879 shares of common stock as additional commitment fee, valued at $24,162, fair value, leaving 222,595 in reserve for additional commitment fees. In January 2019, the Company signed a Purchase Agreement with the institutional investor to sell up to $25,000,000 of common stock. The Company registered 9,500,000 shares pursuant to a registration statement filed on January 30, 2019 which became effective February 13, 2019.

STOCK BASED COMPENSATION

STOCK BASED COMPENSATION	12 Months Ended
	Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
STOCK BASED COMPENSATION	NOTE 10 – STOCK BASED COMPENSATION During 2007, the Board of Directors of the Company adopted the 2007 Employee Stock Plan (“2007 Plan”) that was approved by the shareholders. Under the Plan, the Company is authorized to grant options to purchase up to 10,000,000 shares of common stock to directors, officers, employees and consultants who provide services to the Company. The Plan is intended to permit stock options granted to employees under the 2007 Plan to qualify as incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended (“Incentive Stock Options”). All options granted under the 2007 Plan, which are not intended to qualify as Incentive Stock Options are deemed to be non-qualified options (“Non-Statutory Stock Options”). Effective June 24, 2016, the 2007 Plan was terminated. As of December 31, 2018, options to purchase 4,520,000 shares of common stock have been issued and are outstanding. During 2016, the Board of Directors of the Company adopted the 2016 Equity Incentive Plan (“2016 Plan”) that was approved by the shareholders at the 2016 annual meeting of shareholders on May 20, 2016. Under the 2016 Plan, the Company is authorized to grant awards of incentive and non-qualified stock options and restricted stock to purchase up to 3,000,000 shares of common stock to employees, directors and consultants. As of December 31, 2018, options to purchase 2,235,000 shares of common stock have been issued and are outstanding and 755,000 shares of common stock remain available for grants under the 2016 Plan. Both plans are administered by the Board of Directors or its compensation committee which determines the persons to whom awards will be granted, the number of awards to be granted, and the specific terms of each grant. Subject to the provisions regarding Ten Percent Shareholders, the exercise price per share of each option cannot be less than 100% of the fair market value of a share of common stock on the date of grant. Options granted under the 2016 Plan are generally exercisable for a period of 10 years from the date of grant and may vest on the grant date, another specified date or over a period of time. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of an award, with the following assumptions for 2018: no dividend yield in all years, expected volatility, based on the Company’s historical volatility, 60% to 90%, risk-free interest rate between 1.89% to 3.06% and expected option life of 5.0 to 10 years. Prior to May 2018, the expected life is based on the estimated average of the life of options using the “simplified” method, as prescribed in FASB ASC 718, due to insufficient historical exercise activity during recent years. Starting in May 2018, the expected life is based on the legal contractual life of options. The Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of an award, with the following assumptions for 2017: no dividend yield in all years, expected volatility, based on the Company’s historical volatility, 39% to 87%, risk-free interest rate between 1.16% to 2.37% and expected option life of .03 to 9.08 years. As of December 31, 2018, there was $324,497 of unrecognized compensation expense related to non-vested market-based share awards that is expected to be recognized through August 30, 2020. Share-based compensation was recognized as follows: 2018 2017 2007 Employee Stock Option Plan $ 15,149 $ 18,322 2016 Equity Incentive Plan 372,539 776,416 Warrants 78,390 416,934 Total share-based compensation $ 466,078 $ 1,211,672 The following tables summarize all stock option and warrant activity of the Company during the years ended December 31, 2018 and 2017: Non-Qualified Stock Options and Warrants Number of Exercise Weighted Average Shares Price Exercise Price Outstanding, December 31, 2016 18,101,367 $ 0.57 - $1.69 $ 0.90 Granted 1,770,000 $ 0.60 - $1.50 $ 0.97 Expired (772,500 ) $ 0.68 - $1.69 $ 0.98 Forfeited — — — Exercised (469,000 ) $ 1.00. - $1.25 $ 1.07 Outstanding, December 31, 2017 18,629,867 $ 0.57 - $1.69 $ 0.90 Granted 720,000 $ 1.07 - $1.27 $ 1.19 Expired (100,000 ) $ 0.90 - $.90 $ 0.90 Forfeited (85,000 ) $ 0.92 - $1.22 $ 0.96 Exercised (200,000 ) $ 0.615 - $1.00 $ 0.81 Outstanding, December 31, 2018 18,964,867 $ 0.57 - $1.69 $ 0.91 Exercisable, December 31, 2018 18,504,240 $ 0.57 - $1.69 $ 0.90 The aggregate intrinsic value of options and warrants outstanding and exercisable as of December 31, 2018 was $183,350. The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and warrants and the closing stock price of $0.71 for the Company’s common stock on December 31, 2018. The total intrinsic value of options and warrants exercised during the year ended December 31, 2017 was $4,891,501. During the year ending December 31, 2018, 100,000 warrants were exercised for proceeds of $61,500. During the year ending December 31, 2018, 100,000 options were exercised for proceeds of $100,000. No options were exercised during 2017. During 2017, 335,000 warrants were exercised to purchase shares of common stock at a price of $1.00 per share for proceeds of $335,000 and 134,000 warrants were exercised to purchase shares of common stock at a price of $1.25 per share for proceeds of $167,500. Non-Qualified Stock Options and Warrants Outstanding Number Outstanding Weighted Average Weighted Average Range of Currently Exercisable Remaining Exercise Price of Options and Exercise Prices at December 31, 2018 Contractual Life Warrants Currently Exercisable $0.57 - $1.69 18,504,240 3.53 Years $0.90

RELATED PARTY

RELATED PARTY	12 Months Ended
	Dec. 31, 2018
Related Party Transactions [Abstract]
RELATED PARTY	NOTE 11 – RELATED PARTY At December 31, 2018 the Company had a legal and accounting service accrual to related party of $10,999 and travel and office expense accruals of officers in the amount of $2,825. At December 31, 2017 the Company had a legal accrual to related party of $4,725 and travel and office expense accruals of officers in the amount of $4,045. In December 2016, the board of directors approved a grant to a senior advisor effective January 1, 2017 of a warrant to purchase up to 275,000 shares of common stock at a purchase price of $0.60 per share. Using the Black-Scholes Option Pricing Formula, the warrant was valued at $102,222, fair value. In March 2017, the warrant was amended to accelerate full vesting and the revaluation of the warrant at $106,576, fair value, was expensed immediately. During July 2018, the Company issued a warrant to purchase 100,000 shares of common stock at a purchase price of $1.15 per share for professional services to be rendered over a twelve month period commencing July 1, 2018. The warrant was valued at $62,637, fair value upon issuance, using the Black-Scholes Option Pricing Formula. The expense is being recognized based on service terms of the agreement over a twelve month period. For the year ending December 31, 2018, the Company recognized $31,318 of expense. During July 2017, the Company issued a warrant to purchase 150,000 shares of common stock at a purchase price of $1.48 per share for professional services to be rendered over a twelve month period commencing July 1, 2017. The warrant was valued at $124,788, fair value upon issuance, using the Black-Scholes Option Pricing Formula. The warrant was re-valued at $91,995, fair value at December 31, 2017. The expense is being recognized based on service terms of the agreement over a twelve month period. For the years ending December 31, 2018 and 2017, the Company recognized $47,072 and $45,997 of expense. During July 2016, the Company issued a warrant to purchase 150,000 shares of common stock at a purchase price of $0.63 per share for professional services to be rendered over a twelve month period commencing July 1, 2016. The warrant was valued at $60,272, fair value, using the Black-Scholes Option Pricing Formula The warrant was re-valued at $65,941, fair value at June 30, 2017. The expense is being recognized based on service terms of the agreement over a twelve month period. For the years ending December 31, 2018 and 2017, the Company recognized $0 and $40,238 of expense. In December 2017, the Board of Directors approved extension of the warrants previously granted to a Board member extending the term of outstanding warrants to purchase in the aggregate 725,000 shares of common stock at exercise prices ranging from $0.60 per share to $0.98 per share. These warrants were scheduled to expire at various dates starting 2017 to 2021, with the new expiration dates ranging from 2022 to 2026. The total incremental compensation cost resulting from this modification was $224,123 which was expensed during the year ended December 31, 2017. The Company used the Black-Scholes option pricing model to calculate the increase in fair value, with the following assumptions: historical volatility from 39% to 87%, risk-free interest rate from 1.16% to 2.37% and expected option life from .03 to 9.08 years.

RETIREMENT PLAN

RETIREMENT PLAN	12 Months Ended
	Dec. 31, 2018
Retirement Benefits [Abstract]
RETIREMENT PLAN	NOTE 12 – RETIREMENT PLAN The Company established a 401(k) retirement plan covering all eligible employees beginning November 15, 2013. A contribution of $24,587 was charged to expense and accrued for the year ending December 31, 2018 to all eligible non-executive participants. . A contribution of $15,873 was charged to expense and accrued for the year ending December 31, 2017 to all eligible non-executive participants

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2018
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 13 – SUBSEQUENT EVENTS During February 2019, the Company issued three warrants each to purchase 25,000 shares of common stock at a purchase price of $0.64 per share for Advisory Board Agreement services to be rendered over a twelve month period commencing February 15, 2019. The warrants were each valued at $8,455, fair value, using the Black-Scholes Option Pricing Formula, vesting over the next twelve months with each vesting 2,087 immediately, 2,083 vesting per month on the first day of the next eleven months commencing March 1, 2019. The warrants expire in five years. The expense is being recognized based on service terms of the agreement over a twelve month period.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
History and Nature of Business	History and Nature of Business Lightwave Logic, Inc. is a technology Company focused on the development of next generation photonic devices and non-linear optical polymer materials systems for applications in high speed fiber-optic data communications and optical computing markets. Currently the Company is in various stages of photonic device and materials development and evaluation with potential customers and strategic partners. The Company expects to obtain a revenue stream from datacom and telecom devices, sales of non-linear optical polymers, and product development agreements prior to moving into full-scale production. The Company’s current development activities are subject to significant risks and uncertainties, including failing to secure additional funding to operationalize the Company’s technology now under development. Lightwave Logic, Inc., (the “Company”) was organized under the laws of the State of Nevada in 1997 as Eastern Idaho Internet Service, Inc. The Company was engaged in an unrelated business until June 30, 1998, at which time the principal assets of that business were sold and operations were discontinued. The Company was inactive until the acquisition of PSI-TEC Corporation (“PSI-TEC”) on July 14, 2004, which is when the Company commenced with its current business and changed its name to PSI-TEC Holdings, Inc.
Merger	Merger On July 14, 2004, the Company acquired PSI-TEC in a share exchange, which was considered to be a capital transaction in substance rather than a business combination, and was accounted for as a change of capital structure under accounting principles generally accepted in the United States. On October 20, 2006, the Company and PSI-TEC merged and the Company changed its name to Third-Order Nanotechnologies, Inc. On March 10, 2008, the Company changed its name to Lightwave Logic, Inc.
Basis of Presentation	Basis of Presentation The accompanying financial statements are presented in accordance with accounting principles generally accepted in the United States of America.
Estimates	Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results could differ from the estimates.
Cash Equivalents	Cash Equivalents For the purposes of the statement of cash flows, the Company considers all highly liquid instruments with maturities of three months or less at the time of purchase to be cash equivalents.
Concentration of Credit Risk	Concentration of Credit Risk Certain financial instruments potentially subject the Company to concentrations of credit risk. These financial instruments consist primarily of cash. At December 31, 2018, the Company did have deposits with a financial institution that exceed the Federal Depository Insurance coverage.
Property and Equipment	Property and Equipment Equipment is stated at cost. Depreciation is principally provided by use of straight-line methods for financial and tax reporting purposes over the estimated useful lives of the assets, generally 5 years. When property is retired or otherwise disposed of, the cost and accumulated depreciation are removed from the accounts and any resulting gain or loss is included in operations.
Intangible Assets	Intangible Assets Definite-lived intangible assets are stated at cost. Patents are amortized over their estimated useful lives, commencing from the date of grant for the remaining legal lives of the patents. The patents generally have a term of up to 20 years from the date of filing of the earliest related patent application. When certain patent applications are abandoned by the Company for claims that are covered by patents already granted to the Company, the cost of patent applications are removed from the accounts and the resulting expense is reflected in the statement of operations.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company’s financial instruments consist of cash, accounts payable and accrued expenses. The carrying values of cash, accounts payable and accrued expenses approximate fair value because of their short maturities.
Income Taxes	Income Taxes The Company follows Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed annually for temporary differences between the financial statement and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities.
Stock-based Payments	Stock-based Payments The Company accounts for stock-based compensation under the provisions of Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 718, "Compensation - Stock Compensation", which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the shorter of the vesting period or the requisite service periods using the straight-line method. The Company accounts for stock-based compensation awards to nonemployees in accordance with FASB ASC 505-50, "Equity- Based Payments to Non-Employees (“ASC 505-50”). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded as an expense and additional paid in capital in stockholders’ equity over the applicable service periods. Non-employee equity based payments are recorded as an expense over the service period, as if the Company had paid cash for the services. At the end of each financial reporting period, prior to vesting or prior to the completion of the services, the fair value of the equity based payments will be re-measured and the non-cash expense recognized during the period will be adjusted accordingly. Since the fair value of equity based payments granted to non-employees is subject to change in the future, the amount of the future expense will include fair value re-measurements until the equity based payments are fully vested or the service completed. As of June 30, 2018 the Company changed its accounting policy for non-employee equity based payments by adopting FASB ASU 2018-07, which expands Topic 718 to include transactions for acquiring goods and services, from nonemployees.
Loss Per Share	Loss Per Share The Company follows FASB ASC 260, “Earnings per Share”, resulting in the presentation of basic and diluted earnings per share. Because the Company reported a net loss in 2018 and 2017, common stock equivalents, including stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and dilutive loss per share were the same.
Recoverability of Long-Lived Assets	Recoverability of Long-Lived Assets The Company follows FASB ASC 360, “Property, Plant, and Equipment”. Long-lived assets to be held and used are reviewed for impairment whenever events or changes in circumstances indicate that the related carrying amount may not be recoverable. When required, impairment losses on assets to be held and used are recognized based on the excess of the asset’s carrying amount.
Comprehensive Income	Comprehensive Income The Company follows FASB ASC 220.10, “Reporting Comprehensive Income.” Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income. Since the Company has no items of other comprehensive income, comprehensive loss is equal to net loss.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In June 2018, the FASB issued ASU No. 2018-07, Compensation – Stock Compensation (Topic 718), Improvements to Nonemployee Share-Based Payment Accounting. The amendments in this Update expand the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. Prior to this Update, Topic 718 applied only to share-based transactions to employees. Consistent with the accounting requirement for employee share-based payment awards, nonemployee share-based payment awards within the scope of Topic 718 are measured at grant-date fair value of the equity instruments that an entity is obligated to issue when the good has been delivered or the service has been rendered and any other conditions necessary to earn the right to benefit from the instruments have been satisfied. The amendments in this Update are effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods within that fiscal year. Early adoption is permitted, but no earlier than an entity’s adoption date of Topic 606. The adoption of this pronouncement on June 30, 2018 had no material impact on the Company’s financial statements.
Recently Issued Accounting Pronouncements Not Yet Adopted	Recently Issued Accounting Pronouncements Not Yet Adopted In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) In July 2018, the FASB issued ASU No. 2018-11, Leases (Topic 842), Targeted Improvements Leases The Company is in the process of evaluating the above ASUs and estimating lease liabilities and corresponding right-of-use assets as of January 1, 2019.
Reclassifications	Reclassifications Certain reclassifications have been made to the 2017 financial statement in order to conform to the 2018 financial statement presentation.

PREPAID EXPENSES AND OTHER CU_2

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables)	12 Months Ended
	Dec. 31, 2018
Prepaid Expense, Current [Abstract]
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consist of the following: December 31, 2018 December 31, 2017 Insurance $ 226,363 $ 79,403 Prepaid material 46,120 — Rent 21,896 254,978 Other 37,210 20,992 Stock award 6,042 30,208 Deposits — 199,338 $ 337,631 $ 584,919

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	12 Months Ended
	Dec. 31, 2018
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment consists of the following: December 31, 2018 December 31, 2017 Office equipment $ 79,886 $ 82,453 Lab equipment 2,513,459 1,695,604 Furniture 33,128 32,693 Leasehold improvements 220,389 231,859 2,846,862 2,042,609 Less: Accumulated depreciation 1,046,093 865,860 $ 1,800,769 $ 1,176,749

INTANGIBLE ASSETS (Tables)

INTANGIBLE ASSETS (Tables)	12 Months Ended
	Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Patents	Intangible assets consist of the following: December 31, 2018 December 31, 2017 Patents $ 1,184,882 $ 787,403 Less: Accumulated amortization 246,643 181,628 $ 938,239 $ 605,775

LONG TERM EQUIPMENT PURCHASE _2

LONG TERM EQUIPMENT PURCHASE PAYABLE (Tables)	12 Months Ended
	Dec. 31, 2018
Payables and Accruals [Abstract]
Schedule of Outstanding Long Term Equipment Purchase Payable	Outstanding long term equipment purchase payable is comprised of the following: Final Year Interest December 31, December 31, of Maturity Classification Rate 2018 2017 Current 0.00 % $ 178,482 $ 493,597 2019 Long term 0.00 % — 184,294 $ 178,482 $ 677,891

COMMITMENTS (Tables)

COMMITMENTS (Tables)	12 Months Ended
	Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Lease Payments of Operating Leases	The Company is obligated under an operating lease for office and laboratory space. The aggregate minimum future lease payments under the operating leases are as follows: YEARS ENDING DECEMBER 31, AMOUNT 2019 $ 32,432 2020 195,574 2021 201,501 2022 189,837 TOTAL $ 619,344

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Schedule of Income Tax (Benefit) Provision	The income tax (benefit) provision consists of the following: 2018 2017 Current $ — $ — Deferred (1,503,000 ) 5,063,000 Change in valuation allowance 1,503,000 (5,063,000 ) $ — $ —
Schedule of Reconciliation of Statutory Federal Rate to Effective Income Tax Rate	The reconciliation of the statutory federal rate to the Company’s effective income tax rate is as follows: 2018 2017 Amount % Amount % Income tax benefit at U.S. federal income tax rate $ (1,213,000 ) (21 ) $ (1,955,000 ) (34 ) State tax benefit, net of federal tax effect (346,000 ) (6 ) (345,000 ) (6 ) Non-deductible share-based compensation 56,000 1 250,000 4 Tax rate change — — 7,113,000 124 Change in valuation allowance 1,503,000 26 (5,063,000 ) (88 ) $ — — $ — —
Schedule of Components of Deferred Tax Assets	The components of deferred tax assets as of December 31, 2018 and 2017 are as follows: 2018 2017 Deferred tax asset for NOL carryforwards $ 11,892,000 $ 10,440,000 Share-based compensation 1,873,000 1,822,000 Valuation allowance (13,765,000 ) (12,262,000 ) $ — $ —

STOCK BASED COMPENSATION (Table

STOCK BASED COMPENSATION (Tables)	12 Months Ended
	Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Stock-based Compensation Plans	Share-based compensation was recognized as follows: 2018 2017 2007 Employee Stock Option Plan $ 15,149 $ 18,322 2016 Equity Incentive Plan 372,539 776,416 Warrants 78,390 416,934 Total share-based compensation $ 466,078 $ 1,211,672
Schedule of Non-Qualified Stock Options and Warrants Outstanding and Exercisable	The following tables summarize all stock option and warrant activity of the Company during the years ended December 31, 2018 and 2017: Non-Qualified Stock Options and Warrants Number of Exercise Weighted Average Shares Price Exercise Price Outstanding, December 31, 2016 18,101,367 $ 0.57 - $1.69 $ 0.90 Granted 1,770,000 $ 0.60 - $1.50 $ 0.97 Expired (772,500 ) $ 0.68 - $1.69 $ 0.98 Forfeited — — — Exercised (469,000 ) $ 1.00. - $1.25 $ 1.07 Outstanding, December 31, 2017 18,629,867 $ 0.57 - $1.69 $ 0.90 Granted 720,000 $ 1.07 - $1.27 $ 1.19 Expired (100,000 ) $ 0.90 - $.90 $ 0.90 Forfeited (85,000 ) $ 0.92 - $1.22 $ 0.96 Exercised (200,000 ) $ 0.615 - $1.00 $ 0.81 Outstanding, December 31, 2018 18,964,867 $ 0.57 - $1.69 $ 0.91 Exercisable, December 31, 2018 18,504,240 $ 0.57 - $1.69 $ 0.90
Schedule of Non-Qualified Stock Options and Warrants Outstanding, by Exercise Price Range	Non-Qualified Stock Options and Warrants Outstanding Number Outstanding Weighted Average Weighted Average Range of Currently Exercisable Remaining Exercise Price of Options and Exercise Prices at December 31, 2018 Contractual Life Warrants Currently Exercisable $0.57 - $1.69 18,504,240 3.53 Years $0.90

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	12 Months Ended	264 Months Ended
	Dec. 31, 2018	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Estimated useful lives of assets	5 years
Estimated useful life of patents	20 years
Date of incorporation	Jan. 1, 1997
Entity former incorporation name	Third-Order Nanotechnologies, Inc., formerly PSI-Tec Holdings, Inc., formerly Eastern Idaho Internet Service, Inc.
Jurisdiction of incorporation	Nevada
Date of corporate name change	Mar. 10, 2008	Mar. 10, 2008
Disposal of assets discription	The Company was engaged in an unrelated business until June 30, 1998, at which time the principal assets of that business were sold and operations were discontinued.
Date of acquisition		Jul. 14, 2004
Fair value method for acquisition transaction	On July 14, 2004, the Company acquired PSI-TEC in a share exchange, which was considered to be a capital transaction in substance rather than a business combination, and was accounted for as a change of capital structure under accounting principles generally accepted in the United States. On October 20, 2006, the Company and PSI-TEC merged and the Company changed its name to Third-Order Nanotechnologies, Inc. On March 10, 2008, the Company changed its name to Lightwave Logic, Inc.
Name of acquired entity	PSI-TEC Holdings, Inc.
Date of merger		Oct. 20, 2006

MANAGEMENT'S PLANS (Details)

MANAGEMENT'S PLANS (Details) - USD ($)	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended		29 Months Ended
	Jan. 31, 2016	Mar. 15, 2018	Mar. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Mar. 18, 2019	Jan. 31, 2019	May 11, 2018	Jun. 15, 2017
Approximate cash position							$ 2,200,000
Approximate monthly expenditures				$ 585,000
Agreement with an institutional investor to sell common stock and investor committed to invest in common stock (upper limit)				7,861,215
Shares issued, value				$ 172,192	$ 226,093
Common stock, shares authorized				250,000,000	250,000,000	250,000,000
Institutional Investor [Member]
Agreement with an institutional investor to sell common stock and investor committed to invest in common stock (upper limit)	$ 20,000,000
Term of agreement with institutional investor	36 months
Registering shares of common stock	5,000,000			9,500,000		9,500,000			5,000,000	5,000,000
Shares issued, value		$ 1,011,585		$ 4,863,535		$ 12,138,785
Institutional Investor [Member] | Subsequent Event [Member]
Registering shares of common stock								9,500,000
Shares issued, value			$ 1,011,585
Common stock, shares authorized								25,000,000

PREPAID EXPENSES AND OTHER CU_3

PREPAID EXPENSES AND OTHER CURRENT ASSETS (Schedule of Prepaid expenses and other current assets consist) (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Prepaid Expense, Current [Abstract]
Insurance	$ 226,363	$ 79,403
Prepaid material	46,120
Rent	21,896	254,978
Other	37,210	20,992
Stock award	6,042	30,208
Deposits		199,338
Prepaid expenses and other current assets	$ 337,631	$ 584,919

PROPERTY AND EQUIPMENT (Schedul

PROPERTY AND EQUIPMENT (Schedule of Equipment) (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 2,846,862	$ 2,042,609
Less: Accumulated depreciation	1,046,093	865,860
Property and equipment, net	1,800,769	1,176,749
Office equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	79,886	82,453
Lab equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,513,459	1,695,604
Furniture [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	33,128	32,693
Leasehold improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 220,389	$ 231,859

PROPERTY AND EQUIPMENT (Narrati

PROPERTY AND EQUIPMENT (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Property, Plant and Equipment [Line Items]
Depreciation expense	$ 400,780	$ 182,006
Sale of property and equipment	2,500
Gain (loss) on disposal of property and equipment	(10,084)
Equipment [Member]
Property, Plant and Equipment [Line Items]
Sale of property and equipment	2,500
Gain (loss) on disposal of property and equipment	2,500
Retired Property and Equipment [Member]
Property, Plant and Equipment [Line Items]
Gain (loss) on disposal of property and equipment	$ (12,584)

INTANGIBLE ASSETS (Schedule of

INTANGIBLE ASSETS (Schedule of Patents) (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Patents	$ 1,184,882	$ 787,403
Less: Accumulated amortization	246,643	181,628
Intangible assets - net	$ 938,239	$ 605,775

INTANGIBLE ASSETS (Narrative) (

INTANGIBLE ASSETS (Narrative) (Details) - USD ($)	Jun. 11, 2018	Dec. 31, 2018	Dec. 31, 2017
Finite-Lived Intangible Assets [Line Items]
Amortization expense		$ 65,015	$ 95,341
Impairment of capitalized patent costs			48,599
Cost of intangibles		$ 397,479	$ 81,743
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Cost of intangibles	$ 315,000

LONG TERM EQUIPMENT PURCHASE _3

LONG TERM EQUIPMENT PURCHASE PAYABLE (Schedule of Outstanding Long Term Equipment Purchase Payable (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Payables and Accruals [Abstract]
Final Year of Maturity	2019
Interest rate	0.00%
Current portion of equipment purchase	$ 178,482	$ 493,597
Outstanding long term equipment purchase payable		184,294
Total outstanding long term equipment purchase payable	$ 178,482	$ 677,891

COMMITMENTS (Details)

COMMITMENTS (Details) - USD ($)	Dec. 31, 2018	Oct. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
2019	$ 32,432	$ 168,824
2020	195,574
2021	201,501
2022	189,837
TOTAL	$ 619,344

COMMITMENTS (Narrative) (Detail

COMMITMENTS (Narrative) (Details) - USD ($)	1 Months Ended		12 Months Ended
	Nov. 30, 2017	Oct. 30, 2017	Dec. 31, 2018	Dec. 31, 2017
Operating Leased Assets [Line Items]
Lease term		61 months
Lease term beginning		Nov. 1, 2017
Lease term ending		Nov. 30, 2022
Additional Lease term		24 months
Lease rent for first year		$ 168,824	$ 32,432
Percentage of rent increase annual base rent		3.00%
Prepaid rent for November 1, 2017 through October 31, 2019		$ 347,045
Prepaid estimated tenant's proportionate share of operating expenses		186,293
Security deposit		$ 36,524
Rental income received from current premise tenant	$ 260,000
Research and Development Expense [Member]
Operating Leased Assets [Line Items]
Rent expense			149,131	$ 121,228
General and Administrative Expense [Member]
Operating Leased Assets [Line Items]
Rent expense			$ 51,791	$ 25,348

INCOME TAXES (Schedule of Incom

INCOME TAXES (Schedule of Income Tax (Benefit) Provision) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Current
Deferred	(1,503,000)	5,063,000
Change in valuation allowance	1,503,000	(5,063,000)
Total

INCOME TAXES (Schedule of Recon

INCOME TAXES (Schedule of Reconciliation of Statutory Federal Rate to Effective Income Tax Rate) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Income tax benefit at U.S. federal income tax rate	$ (1,213,000)	$ (1,955,000)
State tax benefit, net of federal tax effect	(346,000)	(345,000)
Non-deductible share-based compensation	56,000	250,000
Tax rate change		7,113,000
Change in valuation allowance	1,503,000	(5,063,000)
Total
Income tax benefit at U.S. federal income tax rate	(21.00%)	(34.00%)
State tax benefit, net of federal tax effect	(6.00%)	(6.00%)
Non-deductible share-based compensation	1.00%	4.00%
Tax rate change		124.00%
Change in valuation allowance	26.00%	(88.00%)
Total

INCOME TAXES (Schedule of Compo

INCOME TAXES (Schedule of Components of Deferred Tax Assets) (Details) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Deferred tax asset for NOL carryforwards	$ 11,892,000	$ 10,440,000
Share-based compensation	1,873,000	1,822,000
Valuation allowance	(13,765,000)	(12,262,000)
Total

INCOME TAXES (Narrative) (Detai

INCOME TAXES (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
U.S. statutory corporate tax rate beginning in 2018	21.00%
Increase (decrease) in valuation allowance	$ 1,503,000	$ (5,063,000)
Net operating loss carry forwards	$ 44,044,000
Net operating loss carry forwards expiration date	Dec. 31, 2038
U.S. statutory corporate maximum tax rate prior to the Tax Cuts and Jobs Act	34.00%

STOCKHOLDERS' EQUITY (Details)

STOCKHOLDERS' EQUITY (Details) - USD ($)	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended		29 Months Ended
	Jan. 31, 2016	Mar. 15, 2018	Mar. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Jan. 31, 2019	May 11, 2018	Jun. 15, 2017
Equity Issuance [Line Items]
Agreement with an institutional investor to sell common stock and investor committed to invest in common stock (upper limit)				$ 7,861,215
Share issued, value				$ 172,192	$ 226,093
Common stock, shares authorized				250,000,000	250,000,000	250,000,000
Institutional Investor [Member]
Equity Issuance [Line Items]
Agreement with an institutional investor to sell common stock and investor committed to invest in common stock (upper limit)	$ 20,000,000
Agreement with institutional investor term	36 months
Common stock issued to institutional investor as commitment fee, shares	350,000
Common stock issued to institutional investor as commitment fee	$ 237,965
Common stock reserved for additional commitment fees to the institutional investor	650,000					255,474
Registering shares of common stock	5,000,000			9,500,000		9,500,000		5,000,000	5,000,000
Share issued, shares				4,750,000		12,450,000
Share issued, value		$ 1,011,585		$ 4,863,535		$ 12,138,785
Additional shares issued				158,071		394,526
Additional shares issued, amount				$ 172,192		$ 432,205
Institutional Investor [Member] | Subsequent Event [Member]
Equity Issuance [Line Items]
Common stock reserved for additional commitment fees to the institutional investor			222,595
Registering shares of common stock							9,500,000
Share issued, shares			1,550,000
Share issued, value			$ 1,011,585
Common stock, shares authorized							25,000,000
Additional shares issued			32,879
Additional shares issued, amount			$ 24,162

STOCK BASED COMPENSATION (Narra

STOCK BASED COMPENSATION (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Pricing model used in calculation of grant-date fair value	Black-Scholes
Expected dividend yield
Expected volatility, minimum	60.00%	39.00%
Expected volatility, maximum	90.00%	87.00%
Risk-free interest rate, minimum	1.89%	1.16%
Risk-free interest rate, maximum	3.06%	2.37%
Unrecognized compensation expense related to non-vested market-based share awards	$ 324,497
Non Qualified Stock Options And Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate intrinsic value of options and warrants outstanding and exercisable	$ 183,350
Closing stock price of common stock	$ 0.71
Intrinsic value of options and warrants exercised	$ 4,891,501
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected option life	5 years	11 days
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected option life	10 years	9 months 29 days
Transaction One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants exercised	100,000	335,000
Common stock price		$ 1
Proceeds from warrants exercised	$ 61,500	$ 335,000
Transaction Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants exercised	100,000	134,000
Common stock price		$ 1.25
Proceeds from warrants exercised	$ 100,000	$ 167,500
2007 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common shares available to be purchased through options, issued and outstanding	4,520,000
Number of shares authorized under plan	10,000,000
2016 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common shares available to be purchased through options, issued and outstanding	2,235,000
Number of shares authorized under plan	3,000,000
Common stock remain available for grants	755,000
Exercisable period	10 years

STOCK BASED COMPENSATION (Sched

STOCK BASED COMPENSATION (Schedule of Stock-based Compensation Plans) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based compensation	$ 466,078	$ 1,211,672
2007 Employee Stock Option Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based compensation	15,149	18,322
2016 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based compensation	372,539	776,416
Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based compensation	$ 78,390	$ 416,934

STOCK BASED COMPENSATION (Sch_2

STOCK BASED COMPENSATION (Schedule of Stock Option and Warrant Outstanding and Exercisable) (Details) - Non Qualified Stock Options And Warrants [Member] - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Number of Shares
Outstanding	18,629,867	18,101,367
Granted	720,000	1,770,000
Expired	(100,000)	(772,500)
Forfeited	(85,000)
Exercised	(200,000)	(469,000)
Outstanding	18,964,867	18,629,867
Exercisable	18,504,240
Exercise Price
Outstanding (Lower Limit)	$ 0.57	$ 0.57
Outstanding (Upper Limit)	1.69	1.69
Granted (Lower Limit)	1.07	0.60
Granted (Upper Limit)	1.27	1.50
Expired (Lower Limit)	0.90	0.68
Expired (Upper Limit)	0.90	1.69
Forfeited (Lower Limit)	0.92
Forfeited (Upper Limit)	1.22
Exercised (Lower Limit)	0.615	1
Exercised (Upper Limit)	1	1.25
Outstanding (Lower Limit)	0.57	0.57
Outstanding (Upper Limit)	1.69	1.69
Exercisable (Lower Limit)	0.57
Exercisable (Upper Limit)	1.69
Weighted Average Exercise Price
Outstanding	0.90	0.90
Granted	1.19	0.97
Expired	0.90	0.98
Forfeited	0.96
Exercised	0.81	1.07
Outstanding	0.91	$ 0.90
Exercisable	$ 0.90

STOCK BASED COMPENSATION (Summa

STOCK BASED COMPENSATION (Summary of Stock Option and Warrant Outstanding) (Details) - Non Qualified Stock Options And Warrants [Member] - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Prices (Lower Limit)	$ 0.57	$ 0.57
Exercise Prices (Upper Limit)	1.69	$ 1.69
$0.57 - $1.69 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Prices (Lower Limit)	0.57
Exercise Prices (Upper Limit)	$ 1.69
Number Outstanding Currently Exercisable	18,504,240
Weighted Average Remaining Contractual Life	3 years 6 months 10 days
Exercise Price	$ 0.90

RELATED PARTY (Details)

RELATED PARTY (Details) - USD ($)	1 Months Ended					12 Months Ended
	Jul. 31, 2018	Jul. 31, 2017	Jun. 30, 2017	Mar. 31, 2017	Jul. 31, 2016	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Related Party Transaction [Line Items]
Travel and office expense accruals						$ 37,210	$ 20,992
Minimum [Member]
Related Party Transaction [Line Items]
Expected option life						5 years	11 days
Maximum [Member]
Related Party Transaction [Line Items]
Expected option life						10 years	9 months 29 days
December 2016 Senior Advisor [Member]
Related Party Transaction [Line Items]
Options issued								275,000
Purchase price of options								$ 0.60
Option granted, fair value				$ 106,576				$ 102,222
Issued Warrant For Accounting Services [Member]
Related Party Transaction [Line Items]
Options issued	100,000	150,000
Purchase price of options	$ 1.15	$ 1.48
Option granted, fair value	$ 62,637	$ 124,788				$ 31,318	$ 91,995
Stock option expense						47,072	45,997
Issued Warrant For Accounting Services [Member]
Related Party Transaction [Line Items]
Options issued					150,000
Purchase price of options					$ 0.63
Option granted, fair value			$ 65,941		$ 60,272
Stock option expense						0	$ 40,238
Warrant expiration period							starting 2017 to 2021, with the new expiration dates ranging from 2022 to 2026.
Issued Warrant For Accounting Services [Member]
Related Party Transaction [Line Items]
Options issued							725,000
Stock option expense							$ 224,123
Issued Warrant For Accounting Services [Member] | Minimum [Member]
Related Party Transaction [Line Items]
Purchase price of options							$ 0.60
Fair value, Volatility							39.00%
Risk-free interest rate							1.16%
Expected option life							11 days
Issued Warrant For Accounting Services [Member] | Maximum [Member]
Related Party Transaction [Line Items]
Purchase price of options							$ 0.98
Fair value, Volatility							87.00%
Risk-free interest rate							2.37%
Expected option life							9 years 29 days
Related Party [Member]
Related Party Transaction [Line Items]
Legal accrual						10,999	$ 4,725
Officer [Member]
Related Party Transaction [Line Items]
Travel and office expense accruals						$ 2,825	$ 4,045

RETIREMENT PLAN (Details)

RETIREMENT PLAN (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Retirement Plan
Contributions to 401k plan	$ 24,587	$ 15,873

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - Subsequent Event [Member]	1 Months Ended
	Feb. 28, 2019USD ($)$ / sharesshares
Advisory Board Agreement Services Warrants Tranche 1 [Member]
Subsequent Event [Line Items]
Number of common shares issuable under warrant	25,000
Purchase price | $ / shares	$ 0.64
Fair value of warrants | $	$ 8,455
Expiration period	5 years
Advisory Board Agreement Services Warrants Tranche 1 [Member] | Vesting Immediately [Member]
Subsequent Event [Line Items]
Number of warrants vesting during period	2,087
Advisory Board Agreement Services Warrants Tranche 1 [Member] | Vesting per month on the first day of the next eleven months commencing March 1, 2019 [Member]
Subsequent Event [Line Items]
Number of warrants vesting during period	2,083
Advisory Board Agreement Services Warrants Tranche 2 [Member]
Subsequent Event [Line Items]
Number of common shares issuable under warrant	25,000
Purchase price | $ / shares	$ 0.64
Fair value of warrants | $	$ 8,455
Expiration period	5 years
Advisory Board Agreement Services Warrants Tranche 2 [Member] | Vesting Immediately [Member]
Subsequent Event [Line Items]
Number of warrants vesting during period	2,087
Advisory Board Agreement Services Warrants Tranche 2 [Member] | Vesting per month on the first day of the next eleven months commencing March 1, 2019 [Member]
Subsequent Event [Line Items]
Number of warrants vesting during period	2,083
Advisory Board Agreement Services Warrants Tranche 3 [Member]
Subsequent Event [Line Items]
Number of common shares issuable under warrant	25,000
Purchase price | $ / shares	$ 0.64
Fair value of warrants | $	$ 8,455
Expiration period	5 years
Advisory Board Agreement Services Warrants Tranche 3 [Member] | Vesting Immediately [Member]
Subsequent Event [Line Items]
Number of warrants vesting during period	2,087
Advisory Board Agreement Services Warrants Tranche 3 [Member] | Vesting per month on the first day of the next eleven months commencing March 1, 2019 [Member]
Subsequent Event [Line Items]
Number of warrants vesting during period	2,083